Copyright Reports & Markets. All rights reserved.

Global Buprenorphine Hydrochloride Injection Market Research Report 2021

Request for Sample of this report
Buy now

1 Buprenorphine Hydrochloride Injection Market Overview

  • 1.1 Product Overview and Scope of Buprenorphine Hydrochloride Injection
  • 1.2 Buprenorphine Hydrochloride Injection Segment by Type
    • 1.2.1 Global Buprenorphine Hydrochloride Injection Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 0.3mg / mL
    • 1.2.3 0.3mg / mL
  • 1.3 Buprenorphine Hydrochloride Injection Segment by Application
    • 1.3.1 Global Buprenorphine Hydrochloride Injection Sales Comparison by Application: (2021-2027)
    • 1.3.2 Analgesic
    • 1.3.3 Opioid Antagonist
  • 1.4 Global Buprenorphine Hydrochloride Injection Market Size Estimates and Forecasts
    • 1.4.1 Global Buprenorphine Hydrochloride Injection Revenue 2016-2027
    • 1.4.2 Global Buprenorphine Hydrochloride Injection Sales 2016-2027
    • 1.4.3 Buprenorphine Hydrochloride Injection Market Size by Region: 2016 Versus 2021 Versus 2027

2 Buprenorphine Hydrochloride Injection Market Competition by Manufacturers

  • 2.1 Global Buprenorphine Hydrochloride Injection Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Buprenorphine Hydrochloride Injection Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Buprenorphine Hydrochloride Injection Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Buprenorphine Hydrochloride Injection Manufacturing Sites, Area Served, Product Type
  • 2.5 Buprenorphine Hydrochloride Injection Market Competitive Situation and Trends
    • 2.5.1 Buprenorphine Hydrochloride Injection Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Buprenorphine Hydrochloride Injection Players Market Share by Revenue
    • 2.5.3 Global Buprenorphine Hydrochloride Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Buprenorphine Hydrochloride Injection Retrospective Market Scenario by Region

  • 3.1 Global Buprenorphine Hydrochloride Injection Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Buprenorphine Hydrochloride Injection Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Buprenorphine Hydrochloride Injection Market Facts & Figures by Country
    • 3.3.1 North America Buprenorphine Hydrochloride Injection Sales by Country
    • 3.3.2 North America Buprenorphine Hydrochloride Injection Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Buprenorphine Hydrochloride Injection Market Facts & Figures by Country
    • 3.4.1 Europe Buprenorphine Hydrochloride Injection Sales by Country
    • 3.4.2 Europe Buprenorphine Hydrochloride Injection Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Buprenorphine Hydrochloride Injection Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Buprenorphine Hydrochloride Injection Sales by Region
    • 3.5.2 Asia Pacific Buprenorphine Hydrochloride Injection Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Buprenorphine Hydrochloride Injection Market Facts & Figures by Country
    • 3.6.1 Latin America Buprenorphine Hydrochloride Injection Sales by Country
    • 3.6.2 Latin America Buprenorphine Hydrochloride Injection Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Buprenorphine Hydrochloride Injection Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Buprenorphine Hydrochloride Injection Sales by Country
    • 3.7.2 Middle East and Africa Buprenorphine Hydrochloride Injection Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Buprenorphine Hydrochloride Injection Historic Market Analysis by Type

  • 4.1 Global Buprenorphine Hydrochloride Injection Sales Market Share by Type (2016-2021)
  • 4.2 Global Buprenorphine Hydrochloride Injection Revenue Market Share by Type (2016-2021)
  • 4.3 Global Buprenorphine Hydrochloride Injection Price by Type (2016-2021)

5 Global Buprenorphine Hydrochloride Injection Historic Market Analysis by Application

  • 5.1 Global Buprenorphine Hydrochloride Injection Sales Market Share by Application (2016-2021)
  • 5.2 Global Buprenorphine Hydrochloride Injection Revenue Market Share by Application (2016-2021)
  • 5.3 Global Buprenorphine Hydrochloride Injection Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Siegfried
    • 6.1.1 Siegfried Corporation Information
    • 6.1.2 Siegfried Description and Business Overview
    • 6.1.3 Siegfried Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Siegfried Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.1.5 Siegfried Recent Developments/Updates
  • 6.2 Sanofi
    • 6.2.1 Sanofi Corporation Information
    • 6.2.2 Sanofi Description and Business Overview
    • 6.2.3 Sanofi Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Sanofi Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.2.5 Sanofi Recent Developments/Updates
  • 6.3 Johnson Matthey
    • 6.3.1 Johnson Matthey Corporation Information
    • 6.3.2 Johnson Matthey Description and Business Overview
    • 6.3.3 Johnson Matthey Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Johnson Matthey Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.3.5 Johnson Matthey Recent Developments/Updates
  • 6.4 Mallinckrodt
    • 6.4.1 Mallinckrodt Corporation Information
    • 6.4.2 Mallinckrodt Description and Business Overview
    • 6.4.3 Mallinckrodt Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Mallinckrodt Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.4.5 Mallinckrodt Recent Developments/Updates
  • 6.5 Noramco
    • 6.5.1 Noramco Corporation Information
    • 6.5.2 Noramco Description and Business Overview
    • 6.5.3 Noramco Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Noramco Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.5.5 Noramco Recent Developments/Updates
  • 6.6 Unichemlabs
    • 6.6.1 Unichemlabs Corporation Information
    • 6.6.2 Unichemlabs Description and Business Overview
    • 6.6.3 Unichemlabs Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Unichemlabs Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.6.5 Unichemlabs Recent Developments/Updates
  • 6.7 Arevipharma
    • 6.6.1 Arevipharma Corporation Information
    • 6.6.2 Arevipharma Description and Business Overview
    • 6.6.3 Arevipharma Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Arevipharma Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.7.5 Arevipharma Recent Developments/Updates
  • 6.8 Resonance-labs
    • 6.8.1 Resonance-labs Corporation Information
    • 6.8.2 Resonance-labs Description and Business Overview
    • 6.8.3 Resonance-labs Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 Resonance-labs Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.8.5 Resonance-labs Recent Developments/Updates
  • 6.9 Sun Pharma
    • 6.9.1 Sun Pharma Corporation Information
    • 6.9.2 Sun Pharma Description and Business Overview
    • 6.9.3 Sun Pharma Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Sun Pharma Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.9.5 Sun Pharma Recent Developments/Updates
  • 6.10 Rusan Pharma
    • 6.10.1 Rusan Pharma Corporation Information
    • 6.10.2 Rusan Pharma Description and Business Overview
    • 6.10.3 Rusan Pharma Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 Rusan Pharma Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.10.5 Rusan Pharma Recent Developments/Updates
  • 6.11 Micro Orgo Chem
    • 6.11.1 Micro Orgo Chem Corporation Information
    • 6.11.2 Micro Orgo Chem Buprenorphine Hydrochloride Injection Description and Business Overview
    • 6.11.3 Micro Orgo Chem Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Micro Orgo Chem Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.11.5 Micro Orgo Chem Recent Developments/Updates
  • 6.12 Faranshimi
    • 6.12.1 Faranshimi Corporation Information
    • 6.12.2 Faranshimi Buprenorphine Hydrochloride Injection Description and Business Overview
    • 6.12.3 Faranshimi Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Faranshimi Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.12.5 Faranshimi Recent Developments/Updates
  • 6.13 Teva
    • 6.13.1 Teva Corporation Information
    • 6.13.2 Teva Buprenorphine Hydrochloride Injection Description and Business Overview
    • 6.13.3 Teva Buprenorphine Hydrochloride Injection Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Teva Buprenorphine Hydrochloride Injection Product Portfolio
    • 6.13.5 Teva Recent Developments/Updates

7 Buprenorphine Hydrochloride Injection Manufacturing Cost Analysis

  • 7.1 Buprenorphine Hydrochloride Injection Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Buprenorphine Hydrochloride Injection
  • 7.4 Buprenorphine Hydrochloride Injection Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Buprenorphine Hydrochloride Injection Distributors List
  • 8.3 Buprenorphine Hydrochloride Injection Customers

9 Buprenorphine Hydrochloride Injection Market Dynamics

  • 9.1 Buprenorphine Hydrochloride Injection Industry Trends
  • 9.2 Buprenorphine Hydrochloride Injection Growth Drivers
  • 9.3 Buprenorphine Hydrochloride Injection Market Challenges
  • 9.4 Buprenorphine Hydrochloride Injection Market Restraints

10 Global Market Forecast

  • 10.1 Buprenorphine Hydrochloride Injection Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Buprenorphine Hydrochloride Injection by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Injection by Type (2022-2027)
  • 10.2 Buprenorphine Hydrochloride Injection Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Buprenorphine Hydrochloride Injection by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Injection by Application (2022-2027)
  • 10.3 Buprenorphine Hydrochloride Injection Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Buprenorphine Hydrochloride Injection by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Buprenorphine Hydrochloride Injection by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    0.3mg / mL
    0.3mg / mL

    Segment by Application
    Analgesic
    Opioid Antagonist

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Siegfried
    Sanofi
    Johnson Matthey
    Mallinckrodt
    Noramco
    Unichemlabs
    Arevipharma
    Resonance-labs
    Sun Pharma
    Rusan Pharma
    Micro Orgo Chem
    Faranshimi
    Teva

    Buy now